Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 26833301000001117 | Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 59577001000001111 | Zoton FasTab 15mg (Pfizer Ltd) 28 tablet 4 x 7 tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Is a | Lansoprazole 15mg orodispersible gastro-resistant tablets 28 tablet | true | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Is pack of | Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) | false | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Has active ingredient | Lansoprazole | false | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Has excipient | Aspartame | false | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Has excipient | Lactose | false | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Has excipient | Polysorbate | false | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Discontinued indicator | Never discontinued | true | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Has manufactured dose form | Conventional release oral lyophilisate | false | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Has AMP | Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) | true | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Has specific active ingredient | Lansoprazole | true | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Has dispensed dose form | Orodispersible tablet | false | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Zoton FasTab 15mg orodispersible gastro-resistant tablets (Wyeth Laboratories) 28 tablet 4 x 7 tablets | Has dispensed dose form | Conventional release orodispersible tablet | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR